tradingkey.logo

Cue Biopharma Updates on CUE-101 at DAVA 4th Hawaii Summit

ReutersJul 1, 2025 8:13 PM

- Cue Biopharma Inc CUE.O:

  • CUE BIOPHARMA PROVIDES UPDATE ON MOST ADVANCED CLINICAL STAGE ASSET, CUE-101, PRESENTED BY DR. DIMITRIOS COLEVAS AT THE DAVA 4TH HAWAII GLOBAL SUMMIT ON THORACIC MALIGNANCIES

  • CUE BIOPHARMA INC - ORR OF 50% IN HPV+ R/M HNSCC PATIENTS

  • CUE BIOPHARMA INC - 12-MONTH SURVIVAL OF 88% AND MOS OF 32 MONTHS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI